跳至主要内容
临床试验/NCT00959166
NCT00959166已完成不适用

A Prospective Case-control Study to Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-infection - a PET Study

Imperial College London2 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2009年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
81
试验地点
2
主要终点
Association of 11C-labelled PK11195 Uptake Using PET With Acute HCV and HIV Infection

研究概览

简要总结

This study plans to evaluate what happens to the brain in patients with HIV and early hepatitis C. The investigators will be comparing 3 groups of individuals:

  • Group 1: Individuals with HIV infection and acute (early) hepatitis C infection
  • Group 2: Individuals with HIV infection
  • Group 3: Healthy volunteers

详细描述

Subtle changes to the brain, which doctors find difficult to detect through conversation or examination, may occur in patients with HIV and/or hepatitis C infection. It is not currently known whether the brain is affected in early (or acute) hepatitis C.

Individuals wishing to take part will complete a series of tests assessing different aspects of their brain including:

  • 2 brain scans using different technology:

  • Magnetic resonance imaging (MRI) brain scan with spectroscopy

  • CT PET brain scan

  • A computer game test which measures brain function

  • 2 short questionnaires

Results of these tests will be analyzed and compared between 3 groups.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
25 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • HIV-1 antibody positive for at least 12 months
  • Acute HCV (Blood HCV PCR positive with negative PCR within past 8 months)
  • HCV genotype 1
  • Ability to give informed consent
  • Aged > 25 years
  • Abbreviated Mental Test Score of at least 8/10

排除标准

  • Evidence of established cirrhosis or encephalopathy
  • Commencing or any change to HIV medications within 12 weeks
  • Active opportunistic infection
  • Taking anti-depressants or any psychoactive medications within past 4 weeks
  • Use of benzodiazepines within past 4 weeks
  • Recent significant head injury
  • Established dementia
  • Alcohol dependence or recreational drug misuse
  • Untreated early syphilis
  • Hepatitis B infection (HBsAg positive)
  • Unable to give informed consent
  • Any contraindication to MR scanning

研究组 & 干预措施

HIV/acute HCV coinfection

Other

Subjects with HIV/acute HCV coinfection (aHCV cases) were required to have acute HCV, defined by a new positive plasma HCV RNA test within 12 months of a negative HCV RNA test.

干预措施: PET scan (Other)

HIV mono

Other

HIV-infected individuals without hepatitis C co-infection

干预措施: PET scan (Other)

结局指标

主要结局

Association of 11C-labelled PK11195 Uptake Using PET With Acute HCV and HIV Infection

时间窗: 30 days

Association of 11C-labelled PK11195 uptake using PET with acute HCV and HIV infection by PK11195 PET ligand binding. The ligand PK11195 is selective for the peripheral benzodiazepine binding site and exhibits minimal binding in normal brain. In brain lesions, however, there is a massive increase in binding.

次要结局

  • Ratio of NAA/Cr (N-acetyl Aspartate/Creatine) Cerebral Metabolites(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验